Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
CA 2443732 A1 · Owner: Medical College Of Georgia Research Institute, Inc. · Inventors: Ganapathy, Vadivel; Hatanaka, Takahiro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention has revealed the compounds transportable by ATB0,+. Based on the information about these compounds drugs transportable by ATB0,+ , may be designed producedand screened. Such drugs may serve to treat and/or prevent the diseases in which NOS, phenylglycine carnitine, D-amino NOS, phenylglycine, carnivolved. The ATB0,+ gene may be administered to patients to be used for gene therapy of the diseases as described above.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.